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Abstract The histidine rich protein II (HRPII) from Plasmo-
dium falciparum has been implicated as a heme polymerase which
detoxifies free heme by its polymerization to inactive hemozoin.
Histidine-iron center coordination is the dominant mechanism of
interaction between the amino acid and heme. The protein also
contains aspartate allowing for ionic/coordination interactions
between the carboxylate side chain and the heme metal center.
The pH profile of heme binding and polymerization shows the
possibility of these two types of binding sites being differentiated
by pH. Circular dichroism studies of the protein show that pH
and heme binding cause a change in conformation above pH 6
implying the involvement of His-His+ transitions. Heme binding
at pHs above 6 perturbs HRPII conformation, causing an
increase in helicity.
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1. Introduction
Plasmodium sp., the causative agent of malaria, during the
trophozoite blood stage of its life cycle, degrades erythrocyte
hemoglobin as an essential source of nutrients [1]. The free
heme released as a by-product is toxic, inhibiting vacuolar
processes and damaging cell membranes.
In the host, the enzyme heme oxygenase detoxi¢es free
heme into biliverdin, which in turn is converted by biliverdin
reductase to, and excreted as, water-soluble bilirubin [2]. In
the parasite, which lacks heme oxygenase, detoxi¢cation is by
polymerization of free heme into inert hemozoin [3]. Hemo-
zoin is a compound structurally similar to L-hematin where
ionic bonds link the propionate side chain of one hematin
moiety to the ferric iron atom at the center of the adjacent
hematin moiety [4]. This unique mechanism of heme detoxi¢-
cation by Plasmodia is thus a high-priority target for anti-
parasitic drugs [5]. The antimalarial activity of chloroquine
[6^8] and other antimalarial quinolines [9] is believed to be
through the inhibition of this process.
The mechanism of heme polymerization is being debated
[10]. Dorn et al. [11] have shown that the chemical environ-
ment of the food vacuole, where hemoglobin degradation and
the formation of hemozoin occur, is favorable to heme poly-
merization. Speci¢cally the pH of 4.8^5.3 encourages ionic
polymerization by both shifting the equilibrium of heme
from the W-oxo dimer state to the monomer [10], and allowing
for ionization of the propionic side chains (pK = 5.0 [12]) of
heme. They have shown the ability of hemozoin itself to au-
tocatalyze additional hemozoin [13]. A non-protein acetoni-
trile extract of the trophozoite [10] and non-physiological lip-
ids [14] also catalyze hemozoin formation, questioning the
need for a ‘heme polymerase’ enzyme.
Recent candidates identi¢ed as heme polymerases are the
histidine rich proteins HRPII and HRPIII [15]. These proteins
were shown to be present in the food vacuole, and to unam-
biguously polymerize heme [15]. Synthetic peptides corre-
sponding to a repetitive sequence of HRPII bind heme and
inhibit hemozoin formation in vitro [16]. The similarity of the
repetitive sequence Ala-His-His-Ala-Ala-Asp, to the heme
binding site of histidine rich glycoprotein (HRG), Gly-His-
His-Pro-His-Gly, was also supportive of the hypothesis that
HRPII polymerizes heme [15].
However, in HRG (and most proteins involved in heme
binding with histidine), binding takes place between histidine
and the heme iron center [17]. The histidine side chain has a
pK value of 6.0, and histidine-iron association is only possible
above this value. HRPII, being active as a catalyst in the food
vacuole, which has a pH of 4.8^5.3 ^ below the pKa of histi-
dine ^ must therefore allow for a mode of binding very di¡er-
ent from the norm. HRPII is largely made up of repeats in-
volving three amino acids: histidine (34%), alanine (37%) and
aspartic acid (10%) [18]. The high proportion of aspartic acid
is suggestive of the role of this amino acid in heme binding at
pHs less than 6.0. To probe this hypothesis and to understand
the nature of heme polymerization by HRPII and HRPIII, we
report the variation of recombinant HRPII activity and con-
formation with pH and heme.
2. Materials and methods
2.1. Construction of the HRPII expression vector
Details of the cloning, expression and puri¢cation of HRPII will be
published elsewhere. Brie£y, the gene encoding HRPII was cloned
from the genomic DNA of P. falciparum by polymerase chain reaction
(PCR). The sequences of the primers (sense, 5P-CCGGAATTCAT-
GAATAATTCCGCATTTAAT and antisense, 5P-GCCGACGTC-
GACTTAATGGCGTAGGCAATG-3P) were designed on the basis
of reported DNA sequences of HRPII [18] so as to introduce an
EcoRI site at the N-terminus of the open reading frame and a SalI
site just after the C-terminus. The 0.9 kb PCR product was digested
with EcoRI and SalI and cloned into an expression vector developed
in house [19]. This vector has a strong tightly regulated promoter of
bacteriophage lambda (PL) which is thermoregulated due to the pres-
ence of a heat labile c 1857 repressor. The plasmid was transformed
into Escherichia coli strain BL21 and the sequence was veri¢ed using a
dideoxy sequence method.
2.2. Puri¢cation of HRPII
E. coli BL21 cells harboring the plasmid encoding HRPII were
cultured at 29‡C overnight in 5 ml of LB medium containing
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100 Wg/ml ampicillin and were then transferred to 2 l of the same
medium. The cells were grown for 4 h at 29‡C. When the OD600
reached 0.6, the £ask was shaken in a water bath at 70‡C for 2 min.
The cell growth was continued at 42‡C for 4 h. Cells were harvested,
and disrupted to release the protein using sonication. After centrifu-
gation, the supernatant was loaded onto a 5 ml column of Ni2 NTA-
agarose equilibrated with bu¡er. HRPII was eluted by an imidazole
gradient from 200 to 1000 mM. The HRPII protein was eluted at
about 300 mM imidazole and was dialyzed against di¡erent bu¡ers
for analysis.
2.3. Estimation of heme binding
Stock solutions of hemin (Sigma Chemical Co.) were freshly pre-
pared by dissolving it in a minimal quantity of 0.1 M NaOH, and
¢ltering. The concentration of the stock was determined by diluting
1000-fold in DMSO and measuring the absorbance at 405 nm
(O405 = 170 000 [20]). Forty equivalents of heme was added to a 10 ml
sample containing 10 nM HRPII in 10 mM sodium phosphate bu¡er,
pH 8. The protein concentration was determined using the BCA pro-
tein assay (Pierce Chemical Co.). The pH was lowered with hydro-
chloric acid to the indicated values and the absorption spectrum of
each from 450 to 325 nm was recorded. Volume changes were less
than 5%. The same procedure was followed for heme in phosphate
bu¡er, as a control.
2.4. Hemozoin estimation
Samples of the protein were prepared to a ¢nal concentration of
10 pmol in either 100 mM acetate or phosphate bu¡er depending on
the required pH. 50 nmol of hemin was added to the sample tube
from a freshly prepared stock. Each assay was set up in triplicate and
incubated at 37‡C overnight, on a rotary shaker. The reaction was
stopped by adding 10 Wl of 10% SDS, vortexing and then centrifuging
the sample at 16 000Ug for 1 h at 25‡C. The pellets were resuspended
in 2.5% SDS and sodium bicarbonate solution (100 mM, pH 9.0),
sonicated at low power for 10 s and the pellet was again collected
by centrifugation. This step dissolves most of the free heme attached
to the hemozoin and other non-hemozoin-like adducts which form
spontaneously during the assay. The pellet thus obtained is of poly-
merized heme.
For heme quantitation the pellets were solubilized in 20 mM NaOH
to convert polymerized heme (hemozoin/L-hematin) to hematin and
absorbance was measured at 400 nm.
2.5. Circular dichroism (CD) measurements
CD spectra were recorded in the far UV range from 260 nm to
190 nm, on a Jasco J720 spectropolarimeter with an attached data
processor. CD spectra were acquired for samples prepared in the
bu¡er used. The spectra of the bu¡er alone and with heme were later
subtracted from the recorded spectra. Typical parameters used in re-
cording the spectra were: bandwidth 1 nm, response time 2 s, and
scan speed 100 nm/s, with spectral averaging over ¢ve accumulations.
Data were analyzed using non-linear curve ¢tting with a logistic func-
tion from Sigmaplot (Jandel Scienti¢c).
3. Results and discussion
3.1. E¡ect of pH on binding and polymerization of heme
From the pH pro¢le of HRPII-heme interactions (Fig. 1), a
decrease in the binding is seen below pH 7.3, with a mid-point
around pH 6.5. Other heme binding proteins (e.g. HRG [20]
and hemoplexin [21]) involving histidine-iron interactions
show markedly similar behavior. This rapid fall in binding
is attributed to the change in the charge of the side chain
from His to His+ (pK = 6.0), the positively charged side chain
being unable to bind the metal. In HRG, heme binding re-
duces to baseline levels as only histidine-heme binding is in-
volved, with histidine having an apparent pKa of 5.8 [20].
However, HRPII, in comparison to HRG, shows some resid-
ual binding of heme below pH 6, 3^4-fold lower than binding
at higher pH (Fig. 1). This indicates the possibility of a second
type of binding site, which can be di¡erentiated by pH.
Hemozoin formation by HRPII shows a pattern inversely
related to the binding (Fig. 1), being optimum around pH 5
and reaching baseline levels rapidly above pH 6. This pH
dependent pattern was suggested in an earlier report that de-
¢ned HRPII involvement as a heme polymerase [15] and is
comparable with recent extensive studies on hemozoin forma-
tion [11]. Fig. 1 indicates that hemozoin formation is not
associated with the histidine-iron binding, but with the second
type of binding as suggested by the pH pro¢le of binding.
Metal binding properties are associated with amino acids
containing carboxylate, imidazole and hydroxyl side chains
[22]. The variation of heme binding with pH is consistent
with the model that both histidine and aspartate based inter-
actions with heme are involved. Based on the classical pKa of
these amino acids, binding below pH 6 would be aspartate
carboxylate-metal ionic/coordinate interactions and the in-
creased binding above pH 6 from histidine-metal coordina-
tion. The chemical conditions of the food vacuole, where
Fig. 1. HRPII binding and polymerization of heme: variation with pH.
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Fig. 2. CD spectra of HRPII. E¡ect of heme binding and pH. The ¢gure shows HRPII in bu¡er (solid line) and with 10 (dotted line) and 40
(dashed line) equivalents of heme.
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heme polymerization takes place, do not a¡ect the charged
state of the aspartate side chain (pKa = 4.4).
3.2. Conformational changes with pH and heme
The CD spectrum of rHRPII (Fig. 2) shows a deep negative
peak at 200 nm and a shoulder of varying depth around 220
nm. The spectrum is similar in nature to published spectra of
native HRPII [23]. The negative peak at 200 nm is normally
taken as a signature of random-coil/unordered structure in
polypeptides. A similar curve is shown by polyproline in
TFE, where it forms a left-handed helix with three residues
per turn (denoted a poly pro II or PP II conformation) and
occurs to a signi¢cant extent in globular proteins [24]. Anom-
alous movement on SDS, stability over a broad range of pHs
and temperatures is, however, indicative of a highly ordered
conformation in this protein. A good reference CD spectrum
of a 310 helix is not available owing to the low frequency of
occurrence of this protein, preventing the unambiguous de¢-
nition of HRPII conformation from CD data alone.
The negative ellipticity at 222 nm is a recognized marker of
K-helicity in polypeptides, contributions from other secondary
structures at this wavelength being negligible [25,26]. This
parameter is useful to monitor the e¡ect of pH and heme
binding on the conformation of HRPII. The pH pro¢le of
this parameter with HRPII shows that there are two levels
of helicity below and above pH 6 (Fig. 3). With heme, below
pH 6, there is no change in helicity, but above this pH, in-
creasing additions of heme to the sample cause a correspond-
ing increase in helicity (Fig. 4).
pK values of histidine vary with sequence and chemical
environment [27]. These £uctuations around pH 6 seen in
Figs. 3 and 4 are additional indicators of the involvement of
the His-His+ transition in HRPII-heme interactions, and that
the bulk of the histidine residues maintain pK values close to
the classical pK values. HRPII is largely made up of repeats of
the sequences AHHAAD and AHHAHHAAD [18]. In a 310
helical conformation, the molecule would be amphipathic
with all the alanine residues aligned on one face and the
charged residues on the opposite face. The amphipathic na-
ture of the structure would be lost in an K-helical model. This
model would, thus, be intrinsically unstable as it would in-
volve the exposure of apolar alanine to the solvent. His+ salt
bridges with the negatively charged Asp may stabilize the
increased K-helical content at low pH. The absence of these
salt bridges due to the changed charge state of the His side
chain above pH 6 may explain its reduced K-helical content.
Histidine is, however, capable of binding heme at these pHs.
The perturbation caused by binding of bulky heme to adja-
cent histidine residues, and the exclusion of solvent molecules
by a layering of heme around the protein surface, may stabi-
lize the increased K-helical content above pH 6, seen in Fig. 4.
Heme causes no change to the protein structure below pH 6.
Binding to aspartate, assumed to be the dominant form of
binding at these pHs, would not cause the same perturbations
to conformation as the aspartate residues are spaced 5^8 ami-
no acids apart.
4. Conclusion
The HRPII-heme binding data are suggestive of the two
binding sites possible from the sequence. Based on classical
pK values of histidine and aspartate, binding below pH 6 is
assigned to carboxylate-metal ionic interactions involving as-
partate and the increase in binding above pH 6.0 is attributedFig. 3. E¡ect of pH on the helicity of rHRPII.
Fig. 4. E¡ect of heme binding on helicity of HRPII at di¡erent pH.
a, pH 5; E, pH 5.6; O, pH 6.0; b, pH 6.67; F, pH 7.27; R, pH
8.08.
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to an imidazole-iron center type of binding involving histi-
dine. Hemozoin formation correlates with aspartate binding
and not with histidine binding. On varying pH, a structural
transition is seen around pH 6, consistent with this model.
Binding of heme above pH 6 causes a perturbation in the
conformation with an increase in the helicity of the protein.
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